Cargando…

An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration

PURPOSE: Factor H (FH, encoded by CFH) prevents activation of the complement system's alternative pathway (AP) on host tissues. FH impedes C3 convertase (C3bBb) formation, accelerates C3bBb decay, and is a cofactor for factor I (FI)–catalyzed C3b cleavage. Numerous CFH variants are associated w...

Descripción completa

Detalles Bibliográficos
Autores principales: Biggs, Robyn M., Makou, Elisavet, Lauder, Scott, Herbert, Andrew P., Barlow, Paul N., Katti, Suresh K.
Formato: Online Artículo Texto
Lenguaje:English
Publicado: The Association for Research in Vision and Ophthalmology 2022
Materias:
Acceso en línea:https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716232/
https://www.ncbi.nlm.nih.gov/pubmed/36445700
http://dx.doi.org/10.1167/iovs.63.12.30
_version_ 1784842640617897984
author Biggs, Robyn M.
Makou, Elisavet
Lauder, Scott
Herbert, Andrew P.
Barlow, Paul N.
Katti, Suresh K.
author_facet Biggs, Robyn M.
Makou, Elisavet
Lauder, Scott
Herbert, Andrew P.
Barlow, Paul N.
Katti, Suresh K.
author_sort Biggs, Robyn M.
collection PubMed
description PURPOSE: Factor H (FH, encoded by CFH) prevents activation of the complement system's alternative pathway (AP) on host tissues. FH impedes C3 convertase (C3bBb) formation, accelerates C3bBb decay, and is a cofactor for factor I (FI)–catalyzed C3b cleavage. Numerous CFH variants are associated with age-related macular degeneration (AMD), but their functional consequences frequently remain undetermined. Here, we conduct functional comparisons between a control version of FH (not AMD linked) and 21 AMD-linked FH variants. METHODS: Recombinantly produced, untagged, full-length FH versions were assayed for binding to C3b and decay acceleration of C3bBb using surface-plasmon resonance, FI-cofactor activity using a fluorescent probe of C3b integrity, suppression of C5b-9 assembly on an AP-activating surface, and inhibition of human AP-mediated lysis of sheep erythrocytes. RESULTS: All versions were successfully purified despite below-average yields for Arg2Thr, Arg53Cys, Arg175Pro, Arg175Gln, Ile221Val, Tyr402His, Pro503Ala, Arg567Gly, Gly1194Asp, and Arg1210Cys. Compared to control FH, Arg2Thr, Leu3Val, Ser58Ala, Asp90Gly, Asp130Asn, Gln400Lys, Tyr402His, Gly650Val, Ser890Ile, and Thr965Met showed minimal functional differences. Arg1210C, Arg53His, Arg175Gln, Gly1194Asp, Pro503Ala, Arg53Cys, Arg576Gly, and Arg175Pro (in order of decreasing efficacy) underperformed, while Ile221Val, Arg303Gln, and Arg303Trp were “marginal.” We newly identified variants toward the center of the molecule, Pro503Ala and Arg567Gly, as potentially pathogenic. CONCLUSIONS: Our approach could be extended to other variants of uncertain significance and to assays for noncanonical FH activities, aiming to facilitate selection of cohorts most likely to benefit from therapeutic FH. This is timely as recombinant therapeutic FH is in development for intravitreal treatment of AMD in patients with reduced FH functionality.
format Online
Article
Text
id pubmed-9716232
institution National Center for Biotechnology Information
language English
publishDate 2022
publisher The Association for Research in Vision and Ophthalmology
record_format MEDLINE/PubMed
spelling pubmed-97162322022-12-03 An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration Biggs, Robyn M. Makou, Elisavet Lauder, Scott Herbert, Andrew P. Barlow, Paul N. Katti, Suresh K. Invest Ophthalmol Vis Sci Biochemistry and Molecular Biology PURPOSE: Factor H (FH, encoded by CFH) prevents activation of the complement system's alternative pathway (AP) on host tissues. FH impedes C3 convertase (C3bBb) formation, accelerates C3bBb decay, and is a cofactor for factor I (FI)–catalyzed C3b cleavage. Numerous CFH variants are associated with age-related macular degeneration (AMD), but their functional consequences frequently remain undetermined. Here, we conduct functional comparisons between a control version of FH (not AMD linked) and 21 AMD-linked FH variants. METHODS: Recombinantly produced, untagged, full-length FH versions were assayed for binding to C3b and decay acceleration of C3bBb using surface-plasmon resonance, FI-cofactor activity using a fluorescent probe of C3b integrity, suppression of C5b-9 assembly on an AP-activating surface, and inhibition of human AP-mediated lysis of sheep erythrocytes. RESULTS: All versions were successfully purified despite below-average yields for Arg2Thr, Arg53Cys, Arg175Pro, Arg175Gln, Ile221Val, Tyr402His, Pro503Ala, Arg567Gly, Gly1194Asp, and Arg1210Cys. Compared to control FH, Arg2Thr, Leu3Val, Ser58Ala, Asp90Gly, Asp130Asn, Gln400Lys, Tyr402His, Gly650Val, Ser890Ile, and Thr965Met showed minimal functional differences. Arg1210C, Arg53His, Arg175Gln, Gly1194Asp, Pro503Ala, Arg53Cys, Arg576Gly, and Arg175Pro (in order of decreasing efficacy) underperformed, while Ile221Val, Arg303Gln, and Arg303Trp were “marginal.” We newly identified variants toward the center of the molecule, Pro503Ala and Arg567Gly, as potentially pathogenic. CONCLUSIONS: Our approach could be extended to other variants of uncertain significance and to assays for noncanonical FH activities, aiming to facilitate selection of cohorts most likely to benefit from therapeutic FH. This is timely as recombinant therapeutic FH is in development for intravitreal treatment of AMD in patients with reduced FH functionality. The Association for Research in Vision and Ophthalmology 2022-11-29 /pmc/articles/PMC9716232/ /pubmed/36445700 http://dx.doi.org/10.1167/iovs.63.12.30 Text en Copyright 2022 The Authors https://creativecommons.org/licenses/by/4.0/This work is licensed under a Creative Commons Attribution 4.0 International License.
spellingShingle Biochemistry and Molecular Biology
Biggs, Robyn M.
Makou, Elisavet
Lauder, Scott
Herbert, Andrew P.
Barlow, Paul N.
Katti, Suresh K.
An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
title An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
title_full An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
title_fullStr An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
title_full_unstemmed An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
title_short An Evaluation of the Complement-Regulating Activities of Human Complement Factor H (FH) Variants Associated With Age-Related Macular Degeneration
title_sort evaluation of the complement-regulating activities of human complement factor h (fh) variants associated with age-related macular degeneration
topic Biochemistry and Molecular Biology
url https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9716232/
https://www.ncbi.nlm.nih.gov/pubmed/36445700
http://dx.doi.org/10.1167/iovs.63.12.30
work_keys_str_mv AT biggsrobynm anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT makouelisavet anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT lauderscott anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT herbertandrewp anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT barlowpauln anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT kattisureshk anevaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT biggsrobynm evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT makouelisavet evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT lauderscott evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT herbertandrewp evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT barlowpauln evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration
AT kattisureshk evaluationofthecomplementregulatingactivitiesofhumancomplementfactorhfhvariantsassociatedwithagerelatedmaculardegeneration